Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 26 resources
-
Routemap to eliminating hepatitis C in London: The Opportunity
On 2nd March 2020, the London Joint Working Group on Substance Use and Hepatitis C (LJWG) launched a 'Routemap to eliminating hepatitis C in London'. This document sets out the opportunities for improving hepatitis C care in London, based around five pillars of improvement: reducing stigma; engaging people who are under-served by traditional health systems; working with GPs to find the undiagnosed; reducing pathway attrition; aligning hepatitis C and HIV public health efforts.UK, Greater London Reports & Research, Strategy & Planning PDF -
Hepatitis C in London: 2019 report
This report from Public Health England provides an update on the recent epidemiology of hepatitis C in London. Among the report's statistics are an estimate that 63% of people who inject drugs (PWID) in London had ever been infected with hepatitis C in 2018, with 41% of those ever infected having a current hepatitis C infection. It is estimated that 18% of PWID were unaware of their infection (lower than the 35% unaware in England as a whole). In 2017/18, 87% of eligible clients of drug treatment services received a hepatitis C test, a small increase from 86% in 2016/2017.England, Greater London 17 Feb 2020 Reports & Research PDF -
Summary report: Hepatitis C good practice roadshow, West London - September 2019
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England with the West London ODN on 27th September 2019. The report includes summaries of the workshops held on the day and attendees' reflections and pledges for action.UK, England, Greater London 22 Oct 2019 Training, Reports & Research PDF -
HCV Action and Public Health England hepatitis C good practice roadshow, West London: Presentations
On 27th September 2019, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow with the West London ODN. The event featured presentations on progress in tackling hepatitis C, nationally and locally, and examples of best practice in the prevention, diagnosis, testing and treatment of hepatitis C.UK, England, Greater London 07 Oct 2019 Training, Strategy & Planning PDF -
HCV testing in NSP (Needle and Syringe Provision) Community Pharmacies Pilot (Phase 2)
This report from the London Joint Working Group on Substance Use and Hepatitis C (LJWG) shows the findings from a pilot project providing point of care testing for hepatitis C to people who inject drugs accessing needle and syringe programmes based at community pharmacies in London. Of the 66 people who accepted a test, 39% were hepatitis C RNA positive. 78% of those tested also stated they would prefer to receive HCV treatment in their community pharmacy.UK, Greater London Reports & Research PDF -
Joining the dots: Linking pathways to hepatitis C diagnosis and treatment
This report from the London Joint Working Group on Substance Use and Hepatitis C explores how effective data sharing can lead to quicker, easier access to care for people with hepatitis C. From interviews with various stakeholders, two main barriers to effective data sharing are identified: (1) confusion about who data can be shared with and under what circumstances, (2) a lack of computer systems that enable care providers to easily share patient data.England, Greater London Reports & Research PDF -
EMCDDA on models of care for hepatitis C in drugs services
The European Monitoring Centre for Drugs and Drug Addiction published 'Hepatitis C: new models of care for drugs services' in July 2019. This aims to highlight the importance of targeting people who inject drugs as a key population for the elimination of hepatitis C in Europe and to show innovative practice in the form of 11 case studies (three of which are from England). The report provides key insights into the results, impact, sustainability and transferability of each practice to guide the implementation of these new models of care in other countries and settings.UK, Rest of World, England, Greater London 29 Jul 2019 Reports & Research, Strategy & Planning PDF -
HCV testing in NSP (Needle and Syringe Provision) Community Pharmacies Pilot (Phase 1)
This report from the London Joint Working Group on Substance Use and Hepatitis C (LJWG) provides results from a pilot project providing point of care testing for hepatitis C to people who inject drugs accessing needle and syringe programmes based at community pharmacies in London. Over half of participants tested positive for hepatitis C antibodies and 78% of those engaging with further assessment in secondary care had chronic hepatitis C and were hepatitis C RNA positive.England, Greater London Reports & Research PDF -
Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWID in London
This report, from the London Joint Working Group on Substance Use and Hepatitis C, examines barriers to data collection and onward referral to specialist hepatitis C services for people who inject drugs in London.England, Greater London Reports & Research PDF -
HCV Action good practice case study: Outreach fibroscanning and testing by Imperial College Healthcare NHS Trust
Many people with hepatitis C who access drug and alcohol services face barriers to accessing secondary care. In order to enable this group to have access to specialist services in an environment in which they felt comfortable, the Imperial College Healthcare NHS Trust developed a bespoke outreach fibroscan and testing service for the assessment of hepatitis C and liver disease. The service has operated in drug and alcohol services and homeless hostels, targeting people who may find it otherwise difficult to access secondary care.UK, Greater London Dec 2015 Case study PDF